SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001193125-24-140518
Filing Date
2024-05-16
Accepted
2024-05-16 16:04:22
Documents
2

Document Format Files

Seq Description Document Type Size
1 424B5 d779806d424b5.htm 424B5 481521
2 GRAPHIC g779806g01a04.jpg GRAPHIC 65662
  Complete submission text file 0001193125-24-140518.txt   573187
Mailing Address 321 HARRISON AVENUE SUITE 900 BOSTON MA 02118
Business Address 321 HARRISON AVENUE SUITE 900 BOSTON MA 02118 617-949-2643
Monte Rosa Therapeutics, Inc. (Filer) CIK: 0001826457 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-266003 | Film No.: 24955445
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)